AAP
IRWD icon

Arax Advisory Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Arax Advisory Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$535K Buy
126,966
+125,263
+7,355% +$483K ﹤0.01% 1597
2026
Q1 		$5.98K Buy
1,703
+1,680
+7,304% +$6.89K ﹤0.01% 2701
2025
Q4 		$78 Sell
23
-143,369
-100% -$372K ﹤0.01% 3865
2025
Q3 		$188K Buy
+143,392
New +$148K ﹤0.01% 1287
2024
Q4 		– Sell
-63
Closed -$260 – 2575
2024
Q3 		$260 Buy
+63
New +$339 ﹤0.01% 2488

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Arax Advisory Partners's IRWD Position: Q2 2026 in Review

Arax Advisory Partners increased its Ironwood Pharmaceuticals (IRWD) stake by 7,355% in Q2 2026, buying an estimated $483K and bringing the position to 126,966 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Arax Advisory Partners first reported a position in IRWD in Q3 2024 and has held it in 5 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Arax Advisory Partners held 126,966 shares of Ironwood Pharmaceuticals worth $535K as of Q2 2026.
  • Arax Advisory Partners bought 125,263 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $483K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1597 holding.
  • Arax Advisory Partners first reported a position in Ironwood Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.